日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4

前列腺癌患者的试验设计和目标:前列腺癌工作组4的建议

Armstrong, Andrew J; Morris, Michael J; Abida, Wassim; Aggarwal, Rahul R; Antonarakis, Emmanuel S; Attard, Gerhardt; Beltran, Himisha; Bryce, Alan; Carducci, Michael A; Cheng, Heather H; Chen, Delphine L; Chi, Kim N; Childs, Daniel S; Dahut, William; Emmett, Louise; Fizazi, Karim; Gafita, Andrei; George, Daniel J; Hermann, Ken; Hofman, Michael S; Hope, Thomas; Hussain, Maha; Kelly, W Kevin; Kessler, Elizabeth; Kuo, Phillip H; Lang, Joshua; Liu, Glenn; Marshall, Catherine H; Morgans, Alicia K; McKay, Rana R; Nanus, David; Nelson, Peter; Paller, Channing; Reichert, Zachery R; Ryan, Charles J; Sartor, A Oliver; Schöder, Heiko; Schwartz, Lawrence H; Sharifi, Nima; Stadler, Walter M; Stein, Mark; Sternberg, Cora N; Szmulewitz, Russell Z; Tagawa, Scott T; Sokolova, Alexandra O; Wyatt, Alex W; Yamoah, Kosj; Yu, Evan Y; Halabi, Susan; Scher, Howard I

An in-home engagement and usability study of GeRI: an open-source platform for remote symptom assessment and wearable activity monitoring in men with prostate cancer

一项针对前列腺癌男性患者的GeRI(一个用于远程症状评估和可穿戴活动监测的开源平台)的居家参与度和可用性研究

Mir, Nabiel; Che, Yan; Firoz, Mohammad Taha Bin; Siddiqui, Mohammad Ziad; Mendez, Megan; Huisingh-Scheetz, Megan; Szmulewitz, Russell Z

Tolerability and the Accelerome: Open-Source Wrist Accelerometry Relates to Symptom Burden in Androgen Ablated Older Men with Prostate Cancer

耐受性和加速度组:开源腕部加速度计与接受雄激素剥夺治疗的老年前列腺癌患者的症状负担相关

Mir, Nabiel; Ameranis, Konstantinos; Che, Yan; Szmulewitz, Russell Z; Huisingh-Scheetz, Megan

Enzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial

恩扎卢胺和前列腺特异性抗原水平在转移性前列腺癌中的作用:ARCHES随机临床试验的二次分析

Azad, Arun A; Petrylak, Daniel P; Iguchi, Taro; Shore, Neal D; Villers, Arnauld; Gomez-Veiga, Francisco; Alcaraz, Antonio; Alekseev, Boris; Szmulewitz, Russell Z; Holzbeierlein, Jeffrey; Rosbrook, Brad; Ma, Jie; Zohren, Fabian; El-Chaar, Nader N; Haas, Gabriel P; Stenzl, Arnulf; Armstrong, Andrew J

Impact of First-of-Its-Kind Patient-Facing Pharmacogenetics Tool on Dosing Decisions and Treatment Outcomes

首个面向患者的药物遗传学工具对剂量决策和治疗结果的影响

Cho, Youngwoo; Elahi, Sami; Jack, Matthew M; Campbell, John; Smith, Emily; Knoebel, Randall W; George, David; House, Larry; Yeo, Kiang-Teck J; Karrison, Theodore; Volchenboum, Samuel L; Meltzer, David O; Szmulewitz, Russell Z; Vokes, Everett E; Ratain, Mark J; O'Donnell, Peter H

Differential DNA Methylation in the Benign and Cancerous Prostate Tissue of African American and European American Men

非裔美国男性和欧裔美国男性良性和癌性前列腺组织中DNA甲基化的差异

Chernoff, Meytal; Demanelis, Kathryn; Gillard, Marc; Delgado, Dayana; Gleason, Kevin J; Oliva, Meritxell; Chen, Lin; Williams, Anthony; Szmulewitz, Russel Z; Vander Griend, Donald J; Pierce, Brandon L

Phase II trial protocol of focal prostate ablation combined with androgen deprivation therapy for prostate cancer treatment

前列腺癌治疗中局部前列腺消融联合雄激素剥夺疗法的II期临床试验方案

Koehler, Jason; Lama, Daniel; Mendez, Megan; Hsu, Wei-Wen; Oto, Aytekin; Szmulewitz, Russell; Sidana, Abhinav

Synthesis of DOTA-Based 43Sc Radiopharmaceuticals Using Cyclotron-Produced 43Sc as Exemplified by [43Sc]Sc-PSMA-617 for PSMA PET Imaging

利用回旋加速器生产的 43Sc 合成基于 DOTA 的 43Sc 放射性药物,以用于 PSMA PET 成像的 [43Sc]Sc-PSMA-617 为例

Jason P Meier ,Mohammed Bhuiyan ,Richard Freifelder ,Hannah J Zhang ,Lucas Gonzalez ,Antonino Pusateri ,Hsiu-Ming Tsai ,Lara Leoni ,Kaustab Ghosh ,Erica Markiewicz ,Christopher Henning ,Yuhan Zhang ,Ralph Weichselbaum ,Jerry Nolen ,David A Rotsch ,Chien-Min Kao ,Russell Z Szmulewitz ,Chin-Tu Chen ,Satish K Chitneni

SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.

SOX2 利用 FOXA1 作为异源转录伙伴来驱动耐药性前列腺癌的增殖

Phoenix John T, Budreika Audris, Schmeck Devin A, Kostlan Raymond J, Ferrari Marina G, Young Kristen S, Rogers Charles S, Deegan Carleen D, Bienko Marcus W, Bergom Hannah E, Boytim Ella, Brown Ryan M, Walewicz Julia A, Bhagi Shreya K, Ellis Leigh, Antonarakis Emmanuel S, Drake Justin M, Bawa Pushpinder S, Vellky Jordan E, Williams Anthony, Rezine Natalie M, Rennhack Jonathan P, Fanning Sean W, Hwang Justin H, Szmulewitz Russell Z, Vander Griend Donald J, Kregel Steven

The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide

循环肿瘤细胞 HOXB13 RNA 检测对接受阿比特龙或恩扎卢胺治疗的转移性去势抵抗性前列腺癌 (mCRPC) 患者的影响

Halabi, Susan; Guo, Siyuan; Park, Joseph J; Nanus, David M; George, Daniel J; Antonarakis, Emmanuel S; Danila, Daniel Costin; Szmulewitz, Russell Zelig; McDonnell, Donald P; Norris, John D; Lu, Changxue; Luo, Jun; Armstrong, Andrew J